These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 23321325)
21. Ex vivo expansion of mesenchymal stromal cells. Bernardo ME; Cometa AM; Pagliara D; Vinti L; Rossi F; Cristantielli R; Palumbo G; Locatelli F Best Pract Res Clin Haematol; 2011 Mar; 24(1):73-81. PubMed ID: 21396595 [TBL] [Abstract][Full Text] [Related]
22. Isolation of mesenchymal stem cells from human dermis. Soma T; Kishimoto J; Fisher D Methods Mol Biol; 2013; 989():265-74. PubMed ID: 23483401 [TBL] [Abstract][Full Text] [Related]
23. Isolation and culture of mesenchymal stem cells from mouse compact bone. Short B; Wagey R Methods Mol Biol; 2013; 946():335-47. PubMed ID: 23179842 [TBL] [Abstract][Full Text] [Related]
24. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Horwitz EM; Le Blanc K; Dominici M; Mueller I; Slaper-Cortenbach I; Marini FC; Deans RJ; Krause DS; Keating A; Cytotherapy; 2005; 7(5):393-5. PubMed ID: 16236628 [TBL] [Abstract][Full Text] [Related]
25. The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro. Shen B; Wei A; Whittaker S; Williams LA; Tao H; Ma DD; Diwan AD J Cell Biochem; 2010 Feb; 109(2):406-16. PubMed ID: 19950204 [TBL] [Abstract][Full Text] [Related]
26. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Meisel R; Brockers S; Heseler K; Degistirici O; Bülle H; Woite C; Stuhlsatz S; Schwippert W; Jäger M; Sorg R; Henschler R; Seissler J; Dilloo D; Däubener W Leukemia; 2011 Apr; 25(4):648-54. PubMed ID: 21242993 [TBL] [Abstract][Full Text] [Related]
27. Differential expression of biofunctional GM1 and GM3 gangliosides within the plastic-adherent multipotent mesenchymal stromal cell population. Freund D; Fonseca AV; Janich P; Bornhäuser M; Corbeil D Cytotherapy; 2010 Apr; 12(2):131-42. PubMed ID: 20196693 [TBL] [Abstract][Full Text] [Related]
28. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy. Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829 [TBL] [Abstract][Full Text] [Related]
29. Engineered extracellular matrices modulate the expression profile and feeder properties of bone marrow-derived human multipotent mesenchymal stromal cells. Seib FP; Müller K; Franke M; Grimmer M; Bornhäuser M; Werner C Tissue Eng Part A; 2009 Oct; 15(10):3161-71. PubMed ID: 19358630 [TBL] [Abstract][Full Text] [Related]
30. Rat multipotent mesenchymal stromal cells lack long-distance tropism to 3 different rat glioma models. Bexell D; Gunnarsson S; Svensson A; Tormin A; Henriques-Oliveira C; Siesjö P; Paul G; Salford LG; Scheding S; Bengzon J Neurosurgery; 2012 Mar; 70(3):731-9. PubMed ID: 21869725 [TBL] [Abstract][Full Text] [Related]
31. Heterotopic bone formation derived from multipotent stromal cells is not inhibited in aged mice. Carbonneau CL; Despars G; Beaudry GM; Benabdallah B; Bouhanik S; Dépôt J; Moreau A; Beauséjour CM Cytotherapy; 2014 Aug; 16(8):1073-9. PubMed ID: 24934305 [TBL] [Abstract][Full Text] [Related]
32. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. Phinney DG; Kopen G; Isaacson RL; Prockop DJ J Cell Biochem; 1999 Mar; 72(4):570-85. PubMed ID: 10022616 [TBL] [Abstract][Full Text] [Related]
33. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. Arthur A; Zannettino A; Gronthos S J Cell Physiol; 2009 Feb; 218(2):237-45. PubMed ID: 18792913 [TBL] [Abstract][Full Text] [Related]
34. Human multipotent stromal cells undergo sharp transition from division to development in culture. Larson BL; Ylöstalo J; Prockop DJ Stem Cells; 2008 Jan; 26(1):193-201. PubMed ID: 17916801 [TBL] [Abstract][Full Text] [Related]
35. Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Lee HS; Huang GT; Chiang H; Chiou LL; Chen MH; Hsieh CH; Jiang CC Stem Cells; 2003; 21(2):190-9. PubMed ID: 12634415 [TBL] [Abstract][Full Text] [Related]
36. Isolation and culture of bone marrow-derived human multipotent stromal cells (hMSCs). Wolfe M; Pochampally R; Swaney W; Reger RL Methods Mol Biol; 2008; 449():3-25. PubMed ID: 18370080 [TBL] [Abstract][Full Text] [Related]
37. The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives. Abdallah BM; Kassem M J Cell Physiol; 2009 Jan; 218(1):9-12. PubMed ID: 18726996 [TBL] [Abstract][Full Text] [Related]
38. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. Chen XD; Dusevich V; Feng JQ; Manolagas SC; Jilka RL J Bone Miner Res; 2007 Dec; 22(12):1943-56. PubMed ID: 17680726 [TBL] [Abstract][Full Text] [Related]
39. Low-intensity ultrasound increased colony forming unit-fibroblasts of mesenchymal stem cells during primary culture. Choi WH; Choi BH; Min BH; Park SR Tissue Eng Part C Methods; 2011 May; 17(5):517-26. PubMed ID: 21171932 [TBL] [Abstract][Full Text] [Related]